Kura Oncology, Inc. (KURA)
12.40
+0.51
(+4.29%)
USD |
NASDAQ |
Aug 24, 16:00
13.12
+0.72
(+5.81%)
After-Hours: 20:00
Kura Oncology Price to Book Value : 22.78 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 24, 2026 | 22.78 |
| August 21, 2026 | 21.84 |
| August 20, 2026 | 21.51 |
| August 19, 2026 | 23.01 |
| August 18, 2026 | 22.65 |
| August 17, 2026 | 20.72 |
| August 14, 2026 | 19.95 |
| August 13, 2026 | 18.53 |
| August 12, 2026 | 18.26 |
| August 11, 2026 | 18.24 |
| August 10, 2026 | 18.09 |
| August 07, 2026 | 17.58 |
| August 06, 2026 | 17.04 |
| August 05, 2026 | 16.90 |
| August 04, 2026 | 17.39 |
| August 03, 2026 | 16.88 |
| July 31, 2026 | 16.55 |
| July 30, 2026 | 17.10 |
| July 29, 2026 | 16.40 |
| July 28, 2026 | 17.10 |
| July 27, 2026 | 18.64 |
| July 24, 2026 | 19.08 |
| July 23, 2026 | 19.19 |
| July 22, 2026 | 19.36 |
| July 21, 2026 | 20.00 |
| Date | Value |
|---|---|
| July 20, 2026 | 19.62 |
| July 17, 2026 | 19.95 |
| July 16, 2026 | 20.00 |
| July 15, 2026 | 20.81 |
| July 14, 2026 | 20.64 |
| July 13, 2026 | 20.04 |
| July 10, 2026 | 21.03 |
| July 09, 2026 | 22.19 |
| July 08, 2026 | 22.26 |
| July 07, 2026 | 22.02 |
| July 06, 2026 | 20.28 |
| July 02, 2026 | 20.39 |
| July 01, 2026 | 19.80 |
| June 30, 2026 | 20.15 |
| June 29, 2026 | 9.026 |
| June 26, 2026 | 8.968 |
| June 25, 2026 | 8.524 |
| June 24, 2026 | 8.738 |
| June 23, 2026 | 8.540 |
| June 22, 2026 | 8.524 |
| June 18, 2026 | 8.170 |
| June 17, 2026 | 7.874 |
| June 16, 2026 | 7.734 |
| June 15, 2026 | 7.849 |
| June 12, 2026 | 7.446 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Inovio Pharmaceuticals, Inc. | 23.55 |
| Fortress Biotech, Inc. | 0.5946 |
| Syndax Pharmaceuticals, Inc. | 115.55 |
| Spero Therapeutics, Inc. | 1.598 |
| Gossamer Bio, Inc. | -- |
Price to Book Value Related Metrics
| PS Ratio | 14.18 |
| PEG Ratio | -0.0754 |
| Price | 12.40 |
| Earnings Yield | -27.11% |
| Market Cap | 1.103B |
| PEGY Ratio | -0.0754 |